Value-Based Pricing of US Prescription Drugs: Estimated Savings Using Reports From the Institute for Clinical and Economic Review

This cross-sectional study estimates how annual US drug spending would change if prices for prescription drugs were set at the value-based price.

Detalles Bibliográficos
Autores principales: Yeung, Kai, Bloudek, Lisa, Ding, Yao, Sullivan, Sean D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856524/
https://www.ncbi.nlm.nih.gov/pubmed/36484998
http://dx.doi.org/10.1001/jamahealthforum.2022.4631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856524/
https://www.ncbi.nlm.nih.gov/pubmed/36484998
http://dx.doi.org/10.1001/jamahealthforum.2022.4631

Ejemplares similares